Clinical evidence clearly suggests that the altered expression of EMT-related markers (e.g., the reduced cell adhesion molecules E-cadherin and increased mesenchymal marker, Vimentin [47,48,49]) is not only involved in CRC metastasis, but also in chemotherapy resistance [50,51,52,53,54,55]. This evidence concerns the gene CDH1 and colorectal carcinoma.